We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA Issues Draft Guidance on Financial Disclosure by Clinical Investigators

06 July 2011

Health and Medical Device Alert

The FDA financial disclosure regulations are designed to help uncover potential investigator bias that may arise due to financial ties between the investigator and the clinical trial sponsor.

Read "FDA issues draft guidance on financial disclosure by clinical investigators"  

Loading data